Market Tracker

03/29 4:57am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

2.03
Delayed Data
As of Mar 28
 -0.30 / -12.88%
Today’s Change
0.49
Today|||52-Week Range
3.05
+107.19%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close2.33
Today’s open2.33
Day’s range1.95 - 2.45
Volume1,252,351
Average volume (3 months)491,467
Market cap$68.5M
Dividend yield--
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)-12.82%
Earnings growth (this year)+7.95%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.84

Competitors

 Today’s
change
Today’s
% change
TRILTrillium Therapeutic...-0.15-2.38%
CGIXCancer Genetics Inc-1.00-19.80%
INISInternational Isotop...-0.00-2.86%
VRMLVermillion Inc0.000.00%
Data as of 3:59pm ET, 03/28/2017

Financials

Next reporting dateMay 12, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$20.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts